ProCAID: a phase I clinical trial to combine the AKT inhibitor AZD5363 with docetaxel and prednisolone chemotherapy for metastatic castration resistant prostate cancer
Crabb, Simon J., Birtle, Alison J., Martin, Karen, Downs, Nichola, Ratcliffe, Ian, Maishman, Tom, Ellis, Mary, Griffiths, Gareth, Thompson, Stuart, Ksiazek, Lidia, Khoo, Vincent, Jones, Robert J.Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-017-0433-4
Date:
February, 2017
File:
PDF, 772 KB
english, 2017
File converter
More search results
More benefits 
